-
Economic Evaluation of the Breast Thermal Activity Indicator Plus Clinical Breast Examination
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Belatacept as Conversion Therapy in the Management of Patients Living With a Renal Graft in France
Sep 9, 2025, 16:22 PM -
Early Impact of the Mazars Review on Reimbursement Timelines in Ireland
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Ovarian Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Assessing Conditional Cash Transfers for Tuberculosis Patients in India: An Extended Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Gaps in Cancer Screening Uptake in Ireland: Trends, Barriers and Policy Implications
Sep 9, 2025, 16:22 PM -
Cost Impact of the Porcine Urinary Bladder Matrix in Patients With Diabetic Foot Ulcer in the United Kingdom
Sep 9, 2025, 16:22 PM -
Cost and Healthcare Resource Utilization Associated With Chronic Inducible Urticaria: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Challenges of Evaluating Individualized Therapies in Health Technology Assessment: A Thematic Review
Sep 9, 2025, 16:22 PM -
Using a Large Language Model (LLM) for Data Extraction of Studies: Learnings From a Targeted Literature Review (TLR) in Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
The Five-Year Budget Impact of Introducing Semaglutide 2.4 mg for Obesity Management in Saudi Arabia: A Real-World Patient Flow and Complication-Driven Model
Sep 9, 2025, 16:22 PM -
From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025
Sep 9, 2025, 16:22 PM -
Effectiveness of Inclisiran and Evolocumab in LDL-C Goal Attainment: A Hybrid Decision Tree-Markov Model Analysis
Sep 9, 2025, 16:22 PM -
Lung-Cancer Diagnostic Trajectories: A Nationwide Process-Mining Cluster Analysis of 18,569 French Patients
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Fixed-Dose Combination Rosuvastatin and Ezetimibe vs. Simvastatin Plus Ezetimibe for the Treatment of Hypercholesterolemia in Patients at High Risk and Very High Risk of Cardiovascular Disease in Algeria
Sep 9, 2025, 16:22 PM -
Can Generative AI Automate Health Economic Model Verification?
Sep 9, 2025, 16:22 PM -
HTA Conflicts in Europe: Agreeing to Disagree?
Sep 9, 2025, 16:22 PM -
What Makes a Medicine Innovative? A Literature Review of Evaluation Frameworks
Sep 9, 2025, 16:22 PM -
Comparing HTA Outcomes and Rationale for Decision Making Between Countries With Mature vs. Newly Founded HTA Systems: Evidence From England, France, and Greece
Sep 9, 2025, 16:22 PM -
Human Alignment on Evaluating LLMs for Literature Review Extraction
Sep 9, 2025, 16:22 PM
